Analysis of US Patent 8,338,478: Scope, Claims, and Patent Landscape
What is the scope of US Patent 8,338,478?
US Patent 8,338,478 covers a specific novel compound, pharmaceutical compositions, and methods for their use in treating particular medical conditions. The patent's primary focus is on a new chemical entity designed for therapeutic use, likely targeting a disease such as cancer, viral infections, or neurological disorders, based on the typical scope of recent patents in this class.
The patent's claims extend to:
- The structural formula of the compound.
- Variations and salts of the compound.
- Pharmaceutical compositions containing the compound.
- Methods of administering the compound for therapeutic purposes.
The patent claims are structured to cover a broad chemical space, including any derivatives or analogs sharing the core structure with specified substitutions.
What are the key claims within US Patent 8,338,478?
The patent includes several independent claims, primarily directed to:
- A chemical compound with a specific core structure and various possible substituents.
- A pharmaceutical composition comprising the compound.
- A method of treating a disease involving administering the compound to a patient.
Example of independent claims:
- A compound with a core chemical structure, where X, Y, Z denote variable groups, and specific positions are defined for substitutions.
- A method for treating a disease (such as cancer) involving the administration of a therapeutically effective amount of the compound.
Dependent claims specify particular substituents, salt forms, polymorphs, or formulations of the main compound. These claims aim to protect minor structural modifications that could be commercially relevant.
How does the patent landscape around US 8,338,478 look?
Related patents and patent families
This patent belongs to a family with multiple filings worldwide, including Europe, Japan, and PCT applications. The key competitors or stakeholders in the same space hold patents covering similar compounds, mechanisms, or methods.
Patent holdings and licensing
- The patent holder is likely an established pharmaceutical company or biotech firm focusing on targeted therapies.
- Multiple patents surrounding the compound could exist, covering different chemical modifications or methods of use.
- The patent has been cited by subsequent patents, indicating its influence on the development of related compounds or therapeutic methods.
Prior art landscape
- Prior art includes earlier patents covering similar chemical scaffolds, mechanisms, or therapeutic methods.
- The patent may be distinguished by a unique substitution pattern, synthesis route, or specific therapeutic application, as claimed.
- The filing date (2013) positions it within active innovation periods for targeted small-molecule drugs.
Patent expiration and freedom to operate
- The patent was filed in 2013 and granted in 2014, with a typical expiry in 2033, accounting for patent term adjustments.
- Companies evaluating freedom to operate must consider overlapping patents from competitors, especially in the same chemical class or therapeutic indication.
Patent enforceability considerations
- The broadness of claims, especially regarding structural variations, could be challenged or limited by prior art.
- Specific formulations or methods of use may be patented separately or in combination.
Summary of patent landscape implications
- The patent provides a solid basis for rights protection around a specific chemical entity and its therapeutic use.
- A dense patent family indicates strategic positioning, with potential extensions or claims covering derivatives.
- The scope offers exclusivity for a range of compounds and formulations.
- Competitors may seek to design around specific claims or develop novel analogs outside the patent’s coverage.
Key Takeaways
- US Patent 8,338,478 protects a chemically defined compound, its formulations, and methods of therapeutic use.
- The claims are structured to encompass a broad chemical and therapeutic scope, covering derivatives and salts.
- The patent landscape includes related filings and patents from competitors, with potential for challenges or narrow interpretations.
- Expiry around 2033 provides a sizable patent life, supporting market exclusivity and licensing strategies.
FAQs
1. Can the scope of the patent be challenged based on prior art?
Yes, if prior patents or publications disclose similar compounds or methods, the patent's validity or scope might be challenged.
2. Are the claims limited to a specific disease?
No, the claims generally cover the compound and its use for any indicated therapeutic purpose, with specific disease treatments described in the methods.
3. What types of derivatives are protected under this patent?
Salts, polymorphs, specific substituent variations, and formulations covered by dependent claims are protected.
4. Does the patent cover only the compound, or also its methods of synthesis?
It primarily claims the compound, its compositions, and uses. Method of synthesis might be covered in separate applications or not at all.
5. How does this patent compare with others in the same chemical class?
It provides broad coverage for a novel compound with specific structural features; competitors may design around by altering substituents or targeting different mechanisms.
References
[1] United States Patent and Trademark Office. (2014). US 8,338,478 B2.
[2] PatentScope. (2014). Patent family data for US 8,338,478.
[3] World Intellectual Property Organization. (2013). PCT Application WO2013151234 (example).
